Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 4/20 | 0.37 |
| ▸ | PDCD1 | Q15116 | 3/20 | 0.37 |
| ▸ | CD274 | Q9NZQ7 | 3/20 | 0.37 |
| ▸ | RARB | P10826 | 2/20 | 0.37 |
| ▸ | RARG | P13631 | 2/20 | 0.37 |
| ▸ | RARA | P10276 | 1/20 | 0.37 |
| ▸ | RXRA | P19793 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3390707 | 0.81 | RARB (0.44) | ALDH1A1GAAMAPTNPSR1TRPA1 | |
| SCHEMBL9266425 | 0.80 | ALDH1A1 (0.45) | ALDH1A1GAAMAPTNPSR1TRPA1 | |
| SCHEMBL7017316 | 0.80 | ALDH1A1 (0.45) | ALDH1A1GAAMAPTNPSR1TRPA1 | |
| SCHEMBL7185668 | 0.80 | ALDH1A1 (0.45) | ALDH1A1GAAMAPTNPSR1TRPA1 | |
| SCHEMBL11492167 | 0.80 | ALDH1A1 (0.43) | ALDH1A1GAAMAPTNPSR1TRPA1 | |
| SCHEMBL3186206 | 0.78 | ALDH1A1 (0.44) | ALDH1A1GAAMAPTNPSR1TRPA1 | |
| SCHEMBL17448809 | 0.76 | RARB (0.41) | ALDH1A1GAAMAPTNPSR1TRPA1 | |
| SCHEMBL9261732 | 0.76 | PPARG (0.36) | TRPA1ACE2PDCD1CD274RARB | |
| SCHEMBL25270009 | 0.75 | TRPA1 (0.41) | MAPTTRPA1ALOX15 | |
| SCHEMBL25221473 | 0.75 | TRPA1 (0.41) | MAPTTRPA1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230295068-A1 | NOVEL CYCLOALKENONE COMPOUND OR SALT THEREOF | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2023-09-21 | — | — | US | disclosed |
| US-20230295068-A1 | NOVEL CYCLOALKENONE COMPOUND OR SALT THEREOF | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2023-09-21 | — | — | US | disclosed |
| US-20230295068-A1 | NOVEL CYCLOALKENONE COMPOUND OR SALT THEREOF | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2023-09-21 | — | — | US | disclosed |
| WO-2023153422-A1 | CRYSTAL FORM OF CYCLOHEXENONE COMPOUND | 大鵬薬品工業株式会社 | 2023-08-17 | — | — | WO | disclosed |
| EP-4194435-A1 | NOVEL CYCLOALKENONE COMPOUND OR SALT THEREOF | Taiho Pharmaceutical Co., Ltd. (JP) | 2023-06-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295068-A1 | NOVEL CYCLOALKENONE COMPOUND OR SALT THEREOF | BDNF, SMN1; SMN2, ELAVL1 | ALDH1A1 1225/4885GAA 1989/4885MAPT 196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.